See All Slides - tctmd.com

Slides

Presentation

Culprit-Vessel vs Multivessel Intervention at the Time of Primary PCI in Patients With STEMI and Multivessel Disease

Presenter: M. Bilal Iqbal

November 03, 2014

Presentation

Postprocedural Hemodiafiltration in ACS Patients With Renal and Cardiac Dysfunction Undergoing Urgent, Emergent Coronary Angiography

Presenter: Giancarlo Marenzi

November 02, 2014

Presentation

Bioresorbable Scaffold (BRS) Induces Neointimal Cap That Seals Plaque Without Compromising Lumen Size

Presenter: C.V. Bourantas

November 02, 2014

Presentation

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

Presenter: M.K. Lam

October 31, 2014

Presentation

Chronic Vitamin K Antagonist Therapy and Bleeding Risk in STEMI Patients

Presenter: Wassef Karrowni

October 30, 2014

Presentation

Risk Model for Estimating the 1-Year Risk of Intervention Following Deferred Revascularization After FFR Assessment

Presenter: J.P. Depta

October 29, 2014

Presentation

Systolic and Diastolic BP Changes in Relation with MI and Stroke in Patients With CAD

Presenter: Paolo Verdecchia

October 29, 2014

Presentation

Costs of Periprocedural Complications in Patients Treated With TAVR

Presenter: Suzanne V. Arnold

October 28, 2014

Presentation

New-Generation DES Reduce Stent Thrombosis and MI

Presenter: Luigi Vignali

October 28, 2014

Presentation

National Trends in the Utilization of Short-term Mechanical Circulatory Support

Presenter: R. Stretch

October 27, 2014

Advertisement

Slides

Culprit-Vessel vs Multivessel Intervention at the Time of Primary PCI in Patients With STEMI and Multivessel Disease

Postprocedural Hemodiafiltration in ACS Patients With Renal and Cardiac Dysfunction Undergoing Urgent, Emergent Coronary Angiography

Bioresorbable Scaffold (BRS) Induces Neointimal Cap That Seals Plaque Without Compromising Lumen Size

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

Chronic Vitamin K Antagonist Therapy and Bleeding Risk in STEMI Patients

Risk Model for Estimating the 1-Year Risk of Intervention Following Deferred Revascularization After FFR Assessment

Systolic and Diastolic BP Changes in Relation with MI and Stroke in Patients With CAD

Costs of Periprocedural Complications in Patients Treated With TAVR

New-Generation DES Reduce Stent Thrombosis and MI

National Trends in the Utilization of Short-term Mechanical Circulatory Support

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content